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Pancreatic islets regulate glucose homeostasis through coordinated
actions of hormone-secreting cells. What underlies the function of
the islet as a unit is the close approximation and communication
among heterogeneous cell populations, but the structural mediators
of islet cellular cross talk remain incompletely characterized. We
generated mice specifically lacking β-cell primary cilia, a cellular or-
ganelle that has been implicated in regulating insulin secretion, and
found that the β-cell cilia are required for glucose sensing, calcium
influx, insulin secretion, and cross regulation of α- and δ-cells. Pro-
tein expression profiling in islets confirms perturbation in these
cellular processes and reveals additional targets of cilia-dependent
signaling. At the organism level, the deletion of β-cell cilia disrupts
circulating hormone levels, impairs glucose homeostasis and fuel
usage, and leads to the development of diabetes. Together, these find-
ings demonstrate that primary cilia not only orchestrate β-cell–intrinsic
activity but also mediate cross talk both within the islet and from islets
to other metabolic tissues, thus providing a unique role of cilia in nu-
trient metabolism and insight into the pathophysiology of diabetes.
The pancreatic islet secretes hormones required for metabolichomeostasis. Common to all forms of diabetes are a relative
or absolute insulin deficiency and metabolic imbalance associ-
ated with β-cell dysfunction (1). Islet hormone secretion is a
dynamic process determined by not only cell-intrinsic properties,
e.g., ion channels, but also cell–cell connectivity and communi-
cation (2, 3). Primary cilia are a unique regulator of islet cells; a
single primary cilium protrudes from each cell body and occupies
the common luminal space between neighboring islet cells (4, 5).
These hairlike organs are rich with G protein-coupled receptors
(GPCRs) and chemosensory receptors and act as a signaling hub
to direct cellular functions. Structurally, IFT88 is a component of
the intraflagellar transport (IFT) complex and is required for cilia
assembly (6, 7). Loss of IFT88 causes the absence of cilia and leads
to cystic kidney disease in both mice and humans (8, 9).
Primary cilia have been shown to regulate insulin secretion (10),
but it is unclear which events during β-cell glucose-stimulated in-
sulin secretion are under cilia control and how this relates to
whole-body physiology. A high incidence of obesity and diabetes is
found in two human ciliopathies, Bardet–Biedl and Alström syn-
dromes (11, 12). The pathophysiology of cilia-related diabetes is
incompletely understood and likely encompasses combined effects
on feeding behavior, pancreatic development, and glucose handling.
Most animal models of ciliopathy-related diabetes to date have been
global or whole-pancreas knockouts with mixed phenotypes that
cannot be attributed to defects in any specific tissue or cell type (10,
13, 14). Accordingly, there is a lack of mechanistic understanding of
cilia-dependent regulation of the endocrine pancreas.
To specifically examine the role of cilia in β-cell and islet
function, we generated an Ins1-Cre β-cell cilia knockout (βCKO)
mouse and studied its phenotype at the cellular, tissue, and or-
ganismal level. We find that targeted deletion of β-cell cilia
causes not only β-cell secretory failure, as also seen in a recent
Pdx1-Cre cilia KO model (15), but also aberrant α- and δ-cell
hormone secretion and altered systemic energy metabolism. Our
studies implicate primary cilia as a key regulator of glucose-sensing,
cellular synchronicity, and both intra- and intercellular signaling
pathways that govern core islet functions, demonstrating that
primary cilia are required for islet function as a unit and for the
maintenance of energy homeostasis.
Results
INS1-Cre/IFT88-Flox Mice Lack β-Cell Cilia. To determine the role of
primary cilia in β-cell function, we generated βCKO mice by
crossing INS1-Cre (16) with IFT88-Flox mice (17). The INS1-
Cre strain was chosen based on efficient and selective re-
combination in β-cells and established lack of expression in the
central nervous system (16). A parallel tamoxifen-inducible line,
βCKO-ERT2, was generated by crossing IFT88-Flox with INS1-
CreERT2 (16) and was used as a control. Both βCKO and
βCKO-ERT2 mice are on the C57BL/6 background, are fertile
and carry normal-size litters in Mendelian ratios, and produce pups
with no obvious developmental defects at the time of weaning.
Successful cilia knockout was confirmed using immunohisto-
chemistry, qPCR, and immunoblotting. To visualize primary cilia
morphology and distribution in normal islets, we stained healthy
human and mouse islets with three independent cilia markers, in-
cluding Arl13b, polyglutamylated tubulin, and acetylated α-tubulin
(Fig. 1 A and C). We also captured an electron micrograph of a
human β-cell cilium in ultrastructural detail (Fig. 1B). Compared to
wild-type (WT) mice, βCKO mice lack cilia exclusively on islet
β-cells (Fig. 1C), with deletion of IFT88 gene expression confirmed
by qPCR (Fig. 1D) and by immunoblot of IFT88 (Fig. 1E). Residual
Significance
The primary cilium is a small subcompartment of the cell but
has powerful influence on pancreatic islet function. In this
study, we find a critical role for cilia in regulating β-cell function
and energy metabolism. Importantly, the deletion of β-cell cilia
disrupts intercellular communication and leads to islet dys-
function and diabetes, as seen in a number of human ciliopathy
syndromes. These results should help elucidate pathophysiol-
ogy of human ciliopathy and aid the development of phar-
macologic agents targeting primary cilia that may lead to a
more effective treatment for human diabetes.
Author contributions: J.W.H. and D.W.P. designed research; J.W.H., J.H.C., H.E.C., M.R.D.,
X.W.N., and H.F.R. performed research; F.U. and D.W.P. contributed new reagents/ana-
lytic tools; J.H.C., M.R.D., X.W.N., and D.A. analyzed data; and J.W.H. wrote the paper.
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
Data deposition: Any data and materials that can be shared will be released via a Mate-
rials Transfer Agreement. The phosphoprotein and signaling array data have been de-
posited in the Gene Expression Omnibus under accession numbers GSE138856 and
GSE138885.
1To whom correspondence may be addressed. Email: jing.hughes@wustl.edu.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.2001936117/-/DCSupplemental.
First published April 6, 2020.
8912–8923 | PNAS | April 21, 2020 | vol. 117 | no. 16 www.pnas.org/cgi/doi/10.1073/pnas.2001936117
D
ow
nl
oa
de
d 
at
 S
E
R
IA
LS
 D
E
P
A
R
T
M
E
N
T
, W
A
S
H
IN
G
T
O
N
 U
N
IV
E
R
S
IT
Y
 o
n 
A
ug
us
t 2
3,
 2
02
0 
IFT88 expression in knockout islets was likely from α-cells and
other non–β-cells. As a control, we induced β-cell cilia knockout by
treating βCKO-ERT2 mice with tamoxifen and showed that this
depleted cilia in adult islet β-cells and induced hyperglycemia and
glucose intolerance within days of treatment (SI Appendix, Fig. S1).
Primary cilia expression on βCKO-ERT2 islet α-cells and other
non–β-cells was unaffected by tamoxifen, confirming β-cell speci-
ficity of Cre-ERT2 recombination.
Inactivation of β-Cell Cilia Leads to Altered Islet Composition.
Whereas β-cells comprise the predominant cell type in normal
mouse islets, deletion of β-cell cilia resulted in altered islet cel-
lular composition. Flow sorting by FluoZin3 (18) shows that KO
islets contain a lower percentage of functional β-cells (66.9 ±
5.1% KO, 88.4 ± 6.5% WT; Fig. 2A). Whole-pancreas sections
from 8-wk-old βCKO mice reveal normal islet area and circu-
larity scores (Fig. 2 B and C), while β-cell mass as assessed by
insulin-positive areas was decreased (Fig. 2D). Total insulin
content is also lower in KO islets (379 ± 47.9 ng/10 islets KO,
480 ± 36.5 ng/10 islets WT; Fig. 2E), while α-cell mass and
glucagon content are not significantly different between WT and
KO (903 ± 124 ng/10 islets KO, 853 ± 82 pg/10 islets WT). δ-cell
mass and somatostatin content are significantly increased in KO
(756 ± 101 ng/10 islets KO, 409 ± 70 pg/10 islets WT; Fig. 2 D
and E). Despite grossly normal islet architecture seen on paraffin
sections, βCKO islets have altered intraislet collagen deposition
and increased E-cadherin expression (SI Appendix, Fig. S2),
suggesting altered cellular connectivity.
Primary Cilia Mediate Paracrine Regulation of Islet Cells. The se-
cretory function of βCKO islets was examined in both static and
dynamic settings, revealing changes in hormone output from
all major islet cell types. During static incubation when glucose
concentration is raised from 1 to 11 mM, βCKO islets exhibit
impaired glucose-stimulated insulin secretion (Fig. 3A, Left, fold
induction of 1.69 ± 0.38 KO vs. 7.44 ± 0.48 WT). This difference
in secretion capacity exceeds what would be expected from the
modest reduction in β-cell mass (Fig. 2D), suggesting impairment
in the actual β-cell secretory process. Dynamic secretion exper-
iments reveal blunted first-phase insulin secretion to glucose
challenge and slower recovery to baseline in KO compared to
WT islets, a phenotype suggestive of β-cell asynchrony (19)
(Fig. 3B). To confirm that cilia deletion and not developmental
changes directly disrupts β-cell insulin secretion, we induced cilia
knockout in adult βCKO-ERT2 islets using tamoxifen. Repeat
dynamic secretion experiments show that short-term ablation of
primary cilia in islet β-cells diminishes first-phase insulin secre-
tion (SI Appendix, Fig. S1D), recapitulating the defect seen in
constitutive βCKO islets.
We observe a strong effect of β-cell cilia deficiency on α-cell
and δ-cell hormone secretion, which reveals a role for islet cilia
in cross regulating neighboring cells. Glucagon secretion is
higher in βCKO islets under basal conditions at low glucose and
is less inhibited by high glucose (Fig. 3A,Middle, fold suppression
of 1.75 ± 0.62 KO vs. 4.97 ± 0.56 WT). Glucagon dynamic se-
cretion by KO islets shows higher baseline and less glucose
suppression compared to WT islets (Fig. 3C). Somatostatin re-
sponse to glucose is also disrupted, as KO islets secrete 1.7-fold
more somatostatin than WT islets at low glucose but exhibit
damped induction by high glucose (Fig. 3A, Right, fold induction
of 1.80 ± 0.54 KO vs. 2.44 ± 0.63 WT). Collectively, these
changes indicate that β-cell cilia deficiency not only affects in-
sulin release from the β-cell but also leads to an altered hor-
monal milieu in the local islet environment and reduced glucose
response by islet cells en masse.
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Fig. 1. INS1-Cre/IFT88-Flox islets lack β-cell cilia. (A) Normal mouse and human islets have ciliated α-cells and β-cells (majority of non–α-cells). Arl13b, cilia
GTPase; Glucagon, α-cell marker; DAPI, nucleus marker. (Scale bar, 20 μm.) White arrows indicate cilia. (B) Ultrastructural examination of human islets from a
healthy young male reveals a single β-cell primary cilium, with an intact axoneme (white arrow) and basal bodies (black arrows). (Scale bar, 600 nm, main
panel; 100 nm, Inset). (C) INS1-Cre IFT88 knockout (βCKO) mice lack cilia specifically on β-cells, as detected by costaining of insulin and polyglutamylated
tubulin (PolyE, GT335) or acetylated α-tubulin (AcTUB). (Scale bar, 10 μm.) Images are representative of three experiments with four mice each. (D) IFT88 gene
expression is abolished in KO islets. **P = 0.0093. RPL32, housekeeping control. n = 4 mice per genotype. (E) IFT88 protein expression is diminished in KO
islets. β-actin, loading control. Shown are four individual mice; results are representative of three experiments.
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To examine the response of βCKO β-cells to paracrine cues, we
measured insulin secretion in the presence of purified glucagon or
somatostatin. Glucagon treatment augmented insulin secretion from
βCKO islets in a dose-dependent manner, comparable to WT islets
(Fig. 3D). In contrast, somatostatin treatment failed to inhibit insulin
secretion by βCKO islets (Fig. 3E), suggesting that primary cilia
mediate somatostatin responsiveness in β-cells. We also examined
nonparacrine cues using recombinant EphA5-Fc or ephrin-A5-Fc to
stimulate or inhibit the classic juxtacrine pathway known to mediate
islet cell cross talk (20); however, this pathway appears to be in-
dependent of cilia regulation as WT and βCKO islets responded
similarly in both insulin and glucagon secretion (Fig. 3 F and G).
Primary Cilia Regulate β-Cell Ca2+ Response to Glucose. In both
mouse and human islets, β-cell insulin secretion is triggered by
calcium ion influx. The normal Ca2+ activity in the β-cell is
marked by an initial coordinated burst that corresponds to first-
phase insulin secretion, followed by a period of sustained Ca2+
oscillations that corresponds to second-phase insulin secretion
(21, 22). We hypothesized that the defective insulin secretion by
βCKO mice is due to a loss of normal islet Ca2+ dynamics. To
test this, we performed time-lapse imaging of glucose-stimulated
islet calcium flux at cellular resolution.
Purified βCKO or WT islets were loaded with the Ca2+ in-
dicator Fluo-4 AM and imaged while being stimulated with
8 mM glucose. Kymographs depicting Ca2+ response in indi-
vidual cells across the volume of the islet show abnormal β-cell
Ca2+ activation and dyssynchrony in KO islets (Fig. 4 A and B).
Notably, KO islet Ca2+ response lacks both the initial co-
ordinated burst and the oscillatory behavior seen in WT islets
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Fig. 2. Inactivation of β-cell cilia leads to altered islet composition. (A) Dispersed WT and βCKO islets are sorted after gating on SSC-Ahi/FSC-Ahi (P1, intact
cells), FSC-Wlo/FSC-A hi (P2, singlets), and FITChi (FluoZin+ β-cells). KO islets have a reduced abundance of β-cells compared to WT islets. Data are representative
of three experiments, n = 500 islets per experiment. (B) Insulin (red), glucagon (magenta), and somatostatin (green) immunostaining in whole pancreatic
sections from WT and KO mice at 8 to 10 wk of age. (Scale bar, 50 μm). Images are representative of >200 sections examined. (C) WT and βCKO islets have
comparable islet area (P = 0.268) and islet circularity score (P = 0.659). Additional morphometric data are shown in SI Appendix, Fig. S2. (D) Reduced insulin
(**P = 0.0089) and increased somatostatin (**P = 0.0011) in βCKO islets as quantified by immunofluorescence. Glucagon trends low in KO islets but does not
reach significance (P = 0.0747). n = 265 WT and 280 KO islets from six animals each. (E) βCKO islets have reduced total insulin content (*P = 0.0197), normal
glucagon content (P = 0.683), and increased somatostatin content (**P = 0.0033). n = 50 or more groups of 10 islets examined in >10 experiments.
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and instead exhibits a sustained increase in Ca2+ flux through the
glucose response (Fig. 4 C andD). Composite data from 15 randomly
selected regions of interest per genotype show that these defects are
conserved regardless of cellular location within the islet (Fig. 4 E and
F). When islets are pretreated with somatostatin to block the β-cell
glucose response, KO islets are resistant to change in their reaction to
sequential glucose challenge (SI Appendix, Fig. S5), suggesting altered
sensitivity to paracrine cues.
βCKO Mice Develop Glucose Intolerance and Diabetes without Obesity.
To determine themetabolic phenotype of βCKOmice, we performed
body morphometrics and dynamic tests of glucose homeostasis
in vivo. At 8 wk of age, βCKO mice have body weight and length
comparable to age- and sex-matched WT littermates, suggesting
normal development (Fig. 5 A and B). Body composition analysis
by MRI shows similar fat, lean mass, free water, and total body
water content in KO and WT mice (SI Appendix, Fig. S2A).
βCKO mice are protected from diet-induced obesity, as both
males and females exhibit slower weight gain, smaller net weight
gain, and lower total-body adiposity than WT mice over 20 wk of
high-fat feeding (Fig. 5C and SI Appendix, Fig. S2 B and C).
Despite reduced adiposity, KO mice exhibit susceptibility to
diabetes. Both female and male KO mice have higher fasting
blood glucose than WT mice, a difference that persisted after
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Fig. 3. Primary cilia mediate paracrine regulation of islet cells. (A) βCKO islets exhibit altered hormone secretion from β-, α-, and δ-cells. Glucose-stimulated
insulin secretion (GSIS) is present in WT but not KO islets. Glucagon secretion by KO islets is higher at baseline but has a decreased response to glucose
inhibition. Somatostatin secretion is significantly induced by high glucose in WT islets but not KO islets. n = 10 groups of 10 islets. (B) Dynamic insulin secretion
assay shows markedly abnormal GSIS in KO islets. Significant differences between WT and KO are seen during first-phase insulin secretion. n = 5 or more
groups of 50 islets per sample. (C) Dynamic glucagon secretion assay on the same samples as in B shows higher baseline glucagon and variable suppression by
high glucose. (D) Both WT and βCKO β-cells respond to stimulation by exogenous glucagon (GCG) in a dose-dependent manner (WT, P = 0.0497; KO, P =
0.0253). GSIS is impaired in KO islets (P = 0.000485). White bars = WT, gray bars = KO. n = 4 mice per genotype; results are representative of three exper-
iments. (E) WT but not βCKO β-cells respond to inhibition by exogenous somatostatin (SST) at 10 nM (WT, P = 0.0182; KO, P = 0.297) and 100 nM (WT, P =
0.0107; KO, P = 0.348). White bars = WT, gray bars = KO. (F) βCKO β-cells respond normally to juxtacrine modulation via Eph/ephrin-A5. At 4 μg/mL,
recombinant EphA5-Fc stimulates insulin secretion (WT, P = 0.0222; KO, P = 0.00207), while ephrin-A5-Fc inhibits insulin secretion (WT, P = 0.00278; KO, P =
0.0403). (G) βCKO α-cells respond normally to juxtacrine Eph/ephrin modulation, in a pattern reciprocal to the β-cell response. EphA5-Fc inhibits while ephrin-
A5-Fc augments glucagon secretion. Data did not reach statistical significance, but the trend is consistent across treatment doses. *P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001; ns, not significant.
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high-fat feeding (Fig. 5D). βCKO mice have decreased capacity
to secrete insulin in vivo (Fig. 5E), resulting in impaired glucose
clearance (Fig. 5 F and G). These differences are accentuated by
the fact that we use the standard weight-based glucose dosing in
the glucose tolerance test (GTT) (23), resulting in KO mice
receiving less glucose due to lower fat mass, yet they still cannot
clear it as readily as WT mice can. Insulin tolerance tests (ITTs)
show no evidence of insulin resistance in KO mice on chow or
high-fat diet (Fig. 5 H and I), as expected due to their relatively
lean body composition. Taken together, βCKO mice represent a
model of diabetes without obesity, with a defect in glucose-
dependent insulin secretion.
βCKO Mice Exhibit Abnormal Hormone Profile and Energy Metabolism.
Since βCKO mice display fasting hyperglycemia and glucose in-
tolerance, we examined their whole-body glucose dysregulation by
measuring glucoregulatory parameters via circulating hormones.
Tail vein blood from nonfasted mice was used to measure serum
levels of insulin, glucagon, GLP-1, and leptin. Consistent with
their defect in glucose-stimulated insulin secretion during GTT,
βCKO mice have significantly lower nonfasting insulin levels than
those of WT controls (0.35 ± 0.064 vs. 0.66 ± 0.097 ng/mL fe-
males, 0.67 ± 0.12 vs. 1.08 ± 0.14 ng/mL males) (Fig. 6A, first
panel). Glucagon levels vary widely in both KO and WT mice,
with KO exhibiting higher means than WT (14.33 ± 2.87 vs. 6.22 ±
1.15 pg/mL females, 26.48 ± 2.95 vs. 18.04 ± 2.73 pg/mL males)
(Fig. 6A, second panel). Both hypoinsulinemia and hyper-
glucagonemia likely contribute to the diabetic phenotype of βCKO
mice. GLP-1 and leptin levels are comparable among WT and KO
mice (Fig. 6A, third and fourth panels), indicating that these
hormones are not responsible for the altered insulin and glucagon
secretion, nor are the incretin and appetite-regulatory pathways
directly involved in the development of diabetes in βCKO mice.
To examine the effect of β-cell cilia loss on systemic energy
metabolism, we measured respiratory gas exchange, locomotor
activity, food intake, and energy expenditure. Individual metabolic
cage scans show an increased respiratory exchange (CO2/O2)
ratio in high-fat-fed βCKO mice, suggesting a preference for
carbohydrate metabolism in the setting of dietary fat abundance
(Fig. 6 B and C). Energy expenditure in βCKO mice is decreased
over both light and dark cycles despite normal circadian peri-
odicity and amplitude in locomotor activity and food intake.
Together these results show that adult KO mice have impaired
fat metabolism, a surprising observation since both insulin de-
ficiency and glucagon excess promote fatty acid oxidation. Ani-
mals on chow diet show less pronounced differences than on
high-fat diet (SI Appendix, Fig. S4).
Identification of β-Cell Cilia-Dependent Signaling Pathways. Primary
cilia modulate signaling pathways in a cell type–dependent
manner, notably those downstream of Notch, Hedgehog, trans-
forming growth factor beta (TGF-β), and other G protein-coupled
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Fig. 5. βCKO mice develop glucose intolerance and diabetes without obesity. (A) Body weights at age 8 wk are comparable between WT and βCKO mice. (B)
Body lengths as measured by naso-anal distance are comparable between WT and βCKO mice. (C) Body composition as measured by MRI shows resistance to
diet-induced obesity in βCKO mice. Total fat:lean mass ratio increases in WT mice when diet changes from normal chow diet (NCD) to high-fat diet (HFD), but
significantly less so in KO mice. Mean ± SEM, n = 8 to 12 mice per genotype, sex, and diet group (72 total). (D) βCKO mice at 8 to 12 wk of age on chow diet
have significantly higher fasting blood glucose levels than WT mice (females, P = 0.0017; males, P = 0.0096). This difference persists after administration of
high-fat diet (females, P < 0.0001; males, P = 0.0305). (E) Insulin induction at 30 min after intraperitoneal glucose challenge (2 g/kg) in female mice (n = 18WT,
27 KO). WT mice have significant increase in serum insulin. P = 0.00256. KO mice fail to secrete insulin in response to glucose. Fold induction is 2.02 WT, 1.16
KO. P = 0.0048. (F) GTT in female mice on normal chow diet. KO mice have impaired glucose clearance at 30 min (P = 0.00733) and 60 min (P = 0.000184)
following intraperitoneal glucose administration (2 g/kg); n = 35 WT, 33 KO. The area under the curve (AUC) is higher for KO mice (P = 0.0016). (G) GTT in
female mice after 8 wk of high-fat diet. KO mice had higher glucose levels at 0 min (P = 0.0095), 30 min (P = 0.00212), 60 min (P = 0.00129), and 120 min (P =
0.0172) following glucose administration. n = 23 WT, 21 KO. AUC is higher in KO mice (P = 0.0072). (H) Insulin tolerance test on 4-h fasted female mice on
chow diet (n = 8). (I) Insulin tolerance test on 4-h fasted female mice on high-fat diet (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not
significant.
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receptors (24–27). To identify cilia-dependent signaling pathways
in pancreatic islets, we conducted an unbiased profiling of protein
expression and phosphorylation changes associated with β-cell
cilia deletion. Using a phosphoprotein array consisting of 1,318
paired protein-specific and phosphospecific antibodies and a sig-
naling protein array with 1,358 antibodies (28, 29), we identified
over 100 differentially expressed (P < 0.05) proteins and potential
substrates and effectors that participate in cilia-dependent sig-
naling (SI Appendix, Fig. S6A). After the proteome and phos-
phoproteome datasets were ordered by the lowest P value, lowest
false discovery rate (FDR), and highest fold change (FC), gene
ontology analysis showed enrichment in proteins controlling cell
communication, GPCR signaling, TGF signaling, the cell cycle,
and apoptosis, among other pathways (SI Appendix, Fig. S6B).
Fig. 6. βCKO mice exhibit abnormal hormone profile and energy metabolism. (A) Circulating nonfasting hormone levels in age-matched WT and KO mice.
KO mice have significantly lower serum insulin than WT mice (female, P = 0.0114; male, P = 0.039) and higher glucagon (female, P = 0.0064; male, P = 0.0443).
GLP-1 and leptin are not significantly different between WT and KO mice. (B) KO female mice on a high-fat diet exhibit an increased respiratory exchange
ratio and decreased energy expenditure in calorimetry studies. Locomotor activity and food intake are not significantly different between KO and WT. (C)
Similar findings in KO male mice on a high-fat diet. In both male and female cohorts, n = 4 mice per genotype; data are representative of three independent
experiments, and total number examined = 72 mice. *P < 0.05, **P < 0.01; ns, not significant.
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We examined several groups of proteins in detail, each corre-
sponding to functional defects observed in βCKO islets. Intraislet
levels of insulin, glucagon, and somatostatin differ among βCKO
and WT islets (SI Appendix, Fig. S6C, Left). The cullin E3 ligase
family controls intraislet paracrine signaling via somatostatin (30)
and is elevated in KO islets, consistent with abnormally high so-
matostatin seen in both the secretion assay and protein array
(Fig. 3A and SI Appendix, Fig. S6C). We observe concomitant
changes in paracrine factors inducible nitric oxide synthase and
endothelial nitric oxide synthase which are typically released from
islet monocytes or the endothelium in the setting of islet stress
(31–33). The vascular remodeling regulator VEGFR2 and its Tyr-
1175 phosphorylation are decreased in βCKO islets, which may
indicate reduced ability to support vascular function (34, 35).
There are lower steady-state levels of TGFβR2, its signaling ef-
fector Smad3, and β-catenin, which regulate insulin secretion in
addition to other roles in β-cell function (36–39). Synuclein A
inhibits insulin secretion by binding to KATP channels and secre-
tory granules (40), while PDGFR is a cilia-dependent microtubule
modulator (27, 41), and both are increased in βCKO islets.
Loss of cilia resulted in altered cytoskeletal remodeling and
cell–cell connectivity (SI Appendix, Fig. S6C, Middle), including
levels of focal adhesion proteins integrin β1 and E-cadherin,
along with tight junction proteins (claudins), desmosomes (des-
min), intraislet lamin A, and collagen. Together, these can im-
part profound changes in islet cell adhesion, permeability, and
electrochemical coupling (42–46). Potassium channels are criti-
cal conduits of β-cell electrical activity (47, 48), and βCKO islets
exhibit altered levels of voltage-gated K+ channels Kv1.1, Kv1.3,
Kv3.2, inward rectifying Kir2.1, and KCNK4, consistent with
their defect in insulin secretion (SI Appendix, Fig. S6B, Right).
While the protein arrays did not probe for voltage-gated calcium
channel subunits, several key calcium-sensitive signaling path-
ways are detected as altered in βCKO islets. ER stress markers
calreticulin and calnexin are elevated, while CaMK and cal-
modulin, the binding partner of cilia centrioles and acute Ca2+
sensors for vesicle exocytosis (49, 50), were among the most
severely down-regulated factors (SI Appendix, Fig. S6C, Right).
Collectively, these coordinated changes in ion channel and cal-
cium signaling are consistent with reduced β-cell excitation and
secretory function in the absence of primary cilia.
Discussion
Recent work has explored the link between ciliary dysfunction
and diabetes (10, 11, 15, 51). Here we show that primary cilia are
required for multiple aspects of β-cell function, and we globally
survey the cilia-dependent signaling network in islets. Our find-
ings suggest that β-cell primary cilia are required not only for
glucose-mediated insulin secretion but also for reciprocal regu-
lation with α- and δ-cells, pointing to an integrated role of pri-
mary cilia in islet cell cross talk and in the regulation of glucose
homeostasis (Fig. 7).
Our study shows that primary cilia are present on the surface
of normal mouse and human β-cells (Fig. 1 and SI Appendix, Fig.
S1), where they orchestrate a network of intracellular and in-
tercellular events. Through targeted disruption of β-cell primary
cilia, the βCKO mouse gives a specific view of the role of β-cell
cilia in diabetogenesis, which offers more mechanistic insight than
can be gleaned from the complex metabolic phenotypes of whole-
body cilia deficiency (11, 12, 52). In agreement with the recent re-
port of an inducible Pdx1-Cre cilia knockout mouse (15), deletion of
β-cell cilia in our model reduces β-cell secretory function, which
causes a state of relative insulin insufficiency, glucose intolerance,
and diabetes (Figs. 2, 3, and 5). Our βCKO mouse phenocopies
human diabetes in its hypoinsulinemia, hyperglucagonemia, and
abnormal glycemic state (Figs. 5–6). Given the relatively mild nature
of hyperglycemia, the changes in β-cell phenotype in our model is
likely not a secondary effect of glucotoxicity (53–55) but rather re-
sults from disrupted cilia function and the abnormal glucose-sensing
and paracrine dysregulation that ensue.
The second major finding from this study is that the β-cell
cilium functions beyond the regulation of β-cell intrinsic activi-
ties. Intercellular connectivity and feedback regulation among
islet α-, β-, and δ-cells underlies the functionality of the islet as a
unit, while loss of connectivity is a feature of both type 1 and type
2 diabetes (3, 21, 56). Our data demonstrate a critical role for
primary cilia in cellular cross talk within the islet environment
(Figs. 3 and 4 and SI Appendix, Fig. S5). We show that the β-cell
response to somatostatin is critically dependent on the cilia,
consistent with the observation that the somatostatin receptor
SSTR3 localizes to β-cell cilia while other SSTR isoforms may be
nonciliary (57–59). The exact subtype of somatostatin receptor
responsible for transmitting cilia-dependent δ- to β-cell signals
remains to be determined. There has been no report to date of
glucagon receptor localization to cilia in any cell type, consistent
with our observation that the β-cell response to exogenous glu-
cagon was unaffected by the absence of cilia (Fig. 3D).
As islet topology dictates close proximity between the α-, β-,
and δ-cell bodies and their cilia (4) and because the cilium
represents a nexus for GPCR and other receptor signaling, we
Fig. 7. Cilia-dependent signaling pathways in the β-cell. Schematic of primary cilia actions in the islet, including modulation of β-cell–intrinsic functions and
paracrine regulation of α- and δ-cells to produce a coordinated effect on integrative metabolism.
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hypothesized that cilia may transduce multiple types of signals
between neighboring islet cells. Our findings show that the main
signal is paracrine in nature and that the lost reciprocal regula-
tion among α-, β-, and δ-cells via their secreted hormones results
in an inability for the islet to function as a unit. Primary cilia in
human islets likely play an even more prominent role as a cross
talk regulator, given the increased heterogeneity and intermin-
gling of α-, β-, and δ-cells in the human islet (60, 61). As for other
modes of cellular cross talk, others have identified physical cel-
lular extensions on δ-cells that give a structural basis for intraislet
communication (62), as well as cilia-dependent phosphorylation
of Eph/ephrin signaling components (15). In our studies, we find
βCKO islets to have slightly reduced protein levels of select ephrin
family members A7 and B2 [array datasets GSE138885 (29) and
GSE138856 (28)], while other ephrins were not included in the
array. Functionally, both α- and β-cells in βCKO islets have normal
responses to Eph/ephrin-A5 modulation (Fig. 3 F and G), sug-
gesting that ephrin-mediated juxtacrine signals control hormone
secretion independent of cilia. Thus, we favor a model where
juxtacrine signaling occurs in parallel to cilia-regulated paracrine
signaling in islet cells.
Glucose stimulates Ca2+ influx and oscillations in the β-cell, a
process that we show to be cilia dependent. Our functional imaging
studies reveal that cilia-deficient β-cells exhibit abnormal Ca2+ entry
and total abolishment of Ca2+ oscillations, which offers a mecha-
nistic explanation for severely impaired insulin secretion (Figs. 3–4
and SI Appendix, Fig. S5). The molecular basis underlying cellular
Ca2+ regulation by cilia remains to be elucidated. One possibility
would be that β-cells possess Ca2+ channels on their ciliary mem-
brane (63) and that ciliary Ca2+ fluxes serve as gatekeepers of cy-
tosolic Ca2+. Alternately, the cilia may relay signals from ambient
stimuli to open Ca2+ channels on the plasma membrane (64, 65). It
would be prudent to test these scenarios in both mouse and human
β-cells, as there exist considerable differences in their Ca2+ channel
expression, distribution, and activation (66).
A question that remains unanswered is how β-cell cilia modulate
whole-body energy metabolism. Our calorimetry studies suggest
that β-cell cilia are important for systemic energy expenditure and
fuel usage. βCKO mice have reduced body weight and adiposity,
and metabolic differences between WT and KO mice intensified
when animals were challenged with high-fat diet, suggesting that
KOmice had a reduced ability to use fat as a fuel source even when
it is available in excess (Figs. 5–6 and SI Appendix, Fig. S3 and S4).
Of note, the combination of impaired fasting glucose and impaired
glucose tolerance without obesity and insulin resistance distin-
guishes our mouse model from classic type 2 diabetes (67). What is
not yet known is how other metabolic tissues in βCKO mice con-
tributed to their calorimetry phenotype in the setting of altered
circulating insulin and glucagon and what islet products other than
insulin and glucagon might be influencing metabolism.
Primary cilia control cellular homeostasis by regulating protein
stability (68). Our proteomic and phosphoproteomic profiling
classifies cilia-dependent signaling pathways in islets by functional
protein groups. We observed global changes in cellular proteostasis
and specific modulation of pathways governing paracrine signaling,
hormone secretion, islet cell connectivity, and calcium activation,
corresponding to the main deficits identified in βCKO islets (SI
Appendix, Fig. S6). In addition to these functional clusters, our
datasets reveal perturbations in key cellular mechanisms, including
the ubiquitin–proteasome system, mTOR and PI3K/AKT signaling,
and the cell cycle. There is increasing evidence that these processes
exhibit reciprocal regulation onto ciliogenesis itself (69, 70), thus
representing a feedback mechanism in cilia formation and main-
tenance. While these additional pathways were not individually
validated by functional experiments in this study, they should be the
target of future investigations.
Methods
Materials. All antibodies, chemicals, kits, primers, probes, and software are
listed in the SI Appendix, Key Resources Table.
Mice. Ins1-Cre and Ins1-CreERT2 mice from Jackson Laboratories (JAX
#026801, #026802) were crossed to Ift88fl/fl mice (JAX #022409). Wild-type
C57BL/6J (JAX #000664) were used as a control along with Cre−/− or Flox−/−
littermates. Mice were genotyped at weaning by a commercial vendor
(Transnetyx). Mice were fed a standard rodent diet (PicoLab Mouse Diet
5053, 13.2% calories from fat) or a moderately high fat diet (PicoLab Mouse
Diet 5058, 21.6% calories from fat) as specified. Mice were used at 2 to 4 mo
of age for secretion and calcium experiments and between 2 and 12 mo of
age for glucose tolerance and physiology studies. To induce Cre recombination,
βCKO-ERT2 mice were injected daily for 5 d with tamoxifen (50 μg/g body
weight) or corn oil as vehicle control. Animals were maintained in accordance
with Institutional Animal Care and Use Committee regulations at the Wash-
ington University School of Medicine.
Islet Isolation and Culture. Islets were isolated from young adult mice at 2 to 4
mo of age using collagenase digestion with a modified Lacy protocol (71, 72).
Typical yield is 100 to 150 islets per mouse. Isolated islets were recovered
overnight prior to experiments in a 37 °C, 5% CO2 incubator in 10-cm plates
with 15 mL islet media/plate (RPMI 1640 with 10% fetal bovine serum [FBS],
penicillin–streptomycin, and 11 mmol/L glucose). Ex vivo Cre induction was
performed in isolated βCKO-ERT2 islets using 2.5 μmol/L of 4-hydroxy ta-
moxifen (Santa Cruz sc-3542) in the culture media and replenished with
media change every 2 d. Loss of cilia was confirmed by immunostaining and
functional assays within 96 h of tamoxifen treatment. Human islets were
obtained via the Integrated Islet Distribution Program from deceased do-
nors. Upon arrival, human islets were cultured overnight in islet media prior
to experimentation.
Islet Live-Cell Sorting by Flow Cytometry. Isolated islets were dispersed by
incubating in Accutase (Innovative Cell Tech, Cat #AT-104) at 37 °C for 2 ×
5 min and washed with Hanks’ Balanced Salt Solution (HBSS) buffer without
Ca2+ and Mg2+. Dispersed islets were incubated in RPMI supplemented with
10% FBS and 1 μM FluoZin-3 (ThermoFisher F24195) at 37 °C for 20 min to
label β-cells. Islet cells were washed in fluorescence-activated cell sorting
(FACS) buffer (HBSS with 2% FBS), filtered through a 40 μm strainer, and
resuspended in FACS buffer at 1 × 106 cells/mL Cells were sorted on a
FACSAria-II and gated as GFP-positive β-cells or GFP-negative non–β-cells.
FSC:SSC-W gating was used to exclude cell doublets (<10%) from analysis or
collection.
Immunohistochemistry. Isolated islets were washed with PBS and fixed with
4% paraformaldehyde (PFA) for 15 min and permeabilized with 0.3% Triton
X-100 in PBS (PBST) for 10 min at room temperature. After incubation with
blocking buffer PBS with 10% normal goat serum for 1 h at room temper-
ature, islets were incubated overnight at 4 °C with primary antibodies di-
luted in PBST. The next day, islets were washed, incubated with secondary
antibodies for 1 h at room temperature, and washed again in PBST. DAPI
provided nuclear counterstain. Islets were mounted on glass slides with
Prolong Gold Anti-fade (Thermo Fisher P36930). Pancreas sections were ei-
ther flash frozen in optimal cutting temperature (OCT) compound and cut
into cryosections or fixed in zinc formalin (Z-Fix, Thermo Fisher NC9351419)
or 4% PFA (Electron Microscopy Sciences 15710), dehydrated in 10 to 30%
sucrose, and prepared as paraffin or frozen sections. OCT sections were fixed
in methanol and stained using the above methods. All islet and OCT sections
were imaged using an inverted Zeiss LSM880 fluorescence microscope
(Nikon, Ti-E).
Islet Composition Analysis. Paraffin-embedded or 4% PFA-fixed pancreas
sections with 6 to 15 μm thickness were deparaffinized using xylene and
rehydrated with graded alcohol or PBS, respectively. Antigen retrieval was
performed by heating samples in sodium citrate solution (pH 6.0) for 30 min
followed by permeabilizing in 0.1% Triton X and blocking in 2% bovine
serum albumin (BSA) for 1 h. Antibodies used for staining are detailed in SI
Appendix, Key Resources Table. Quantification of cellular composition, in-
cluding islet size, diameter, and β-, α-, and δ-cell mass as defined by gluca-
gon, insulin, and somatostatin-positive signals per islet area, was performed
in ImageJ. Islet contour was manually traced based on the boundaries of
hormone staining, and the number of pixels within the region of interest
was quantified as total islet area. Circularity scores were calculated using the
following formula: circularity = 4π(area/perimeter2), where a value of 1.0
8920 | www.pnas.org/cgi/doi/10.1073/pnas.2001936117 Hughes et al.
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indicates a perfect circle. In total, we analyzed over 200 whole-pancreatic
sections from six to eight age-matched animals per genotype. Islet compo-
sition was analyzed independently by two researchers who were blinded to
the genotype, and results were cross validated.
Quantitative PCR. Isolated mouse islets were lysed in 350 μL of RLT lysis buffer
supplemented with ß-mercaptoethanol per 100 islets. RNA was purified with
a Qiagen RNeasy mini kit, and cDNA was synthesized using a Thermo Fisher
High-Capacity cDNA reverse transcription kit at 200 ng/20 μL. qPCR was
performed in duplicate on a 7900 Step One Plus RT-PCR machine (Applied
Biosystems) using 2× TaqMan Mastermix (Thermo Fisher 4324018) and 20×
TaqMan Gene Expression assay for the IFT88 gene (Thermo Fisher 4331182).
Changes in gene expression were quantified using 2−ΔΔCT, and results were
normalized to the housekeeping gene RPL32.
Western Blot.Mouse islets were isolated and stored at −80 °C until lysis. Using
a minimum of 80 islets per sample, islets were sonicated in 30 μL lysis buffer
(Cell Signaling Technology) containing cOmplete mini protease inhibitor
mixture (Roche) and lysed on ice for 30 min. Protein concentration was
determined by BCA Protein Assay (Thermo Fisher). Lysates were prepared as
15 μg protein/30 μL and denatured at 70 °C for 10 min. Samples were run on
a Mini-Protean 4 to 20% precast gel (BioRad) and transferred to a nitro-
cellulose membrane. Blots were incubated overnight with the primary an-
tibodies anti-β-actin (Abcam ab8226, 1:1,000) and anti-IFT88 (Proteintech
13967-1-AP, 1:1,000). Signal was detected using fluorescent dye–labeled
secondary antibodies (1:10,000). Fluorescence intensity was quantified with
Image Studio Lite (Li-Cor).
Static Secretion Assay. Islets were equilibrated in Krebs-Ringer bicarbonate
Hepes (KRBH) buffer (128.8 mmol/L NaCl, 4.8 mmol/L KCl, 1.2 mmol/L
KH2PO4, 1.2 mmol/L MgSO4·7H2O, 2.5 mmol/L CaCl2, 20 mmol/L Hepes,
5 mmol/L NaHCO3, and 0.1% BSA [pH 7.4]) at 2.8 mmol/L glucose for 45 min
at 37 °C. Islets were then transitioned to 1 or 11 mmol/L glucose for 1 h at
37 °C in groups of 10 to 20 islets per tube. In select experiments (Fig. 3 D–G),
islets were cotreated with glucagon, somatostatin, or recombinant ephrin-
A5-Fc or EphA5-Fc (R&D Systems) during glucose stimulation. Supernatant
was collected after 1 h, and islet hormone content was extracted overnight
in acid-ethanol (1.5% 12 N HCl in 70% ethanol). Insulin, glucagon, and
somatostatin concentrations were measured by enzyme-linked immunosorbent
assay (ELISA), and secretion data were presented as a percentage of hormone
content.
Dynamic Secretion Assay. The perifusion system was assembled as reported
previously (39). Isolated islets were assayed with effluent collected at a
100 μL/min flow rate every 2 min over sequential glucose changes (2, 20,
2 mM). After sample collection, DNA was quantified using the PicoGreen
assay (Life Technologies, P7589), and insulin and glucagon in the effluent
were measured by ELISA.
ELISA. Insulin, glucagon, GLP-1, and leptin ELISA kits were obtained from
Crystal Chem (#90080, #81518, #81508, #90030). The somatostatin ELISA kit
was obtained from Phoenix Pharmaceuticals (EK-060-03). Mouse whole
blood was collected via tail tip, and serum was isolated after clotting by
centrifuging at 10,000 rpm for 10 min. Between 5 and 20 μL of serum or
secretion sample were used for ELISA per the manufacturer’s protocol. Each
sample was assayed in triplicate.
Glucose and Insulin Tolerance Test. Mice were fasted for 6 h before receiving
intraperitoneal injection of 2 g/kg body weight of sterile glucose solution
(GTT) or fasted for 4 h before receiving 0.5 unit/kg body weight of human
recombinant insulin (ITT, HI-213 Lilly). Blood glucose was measured on tail
vein blood at preinjection (0 min) and 15, 30, 60, 90, and 120 min after
glucose or insulin injection. For serum insulin measurements, blood was
taken pre- and postinjection (0 and 30 min), clotted, and centrifuged at
10,000 rpm for 10 min, and serum was assayed for insulin concentration
using ELISA.
Body Composition and Metabolic Phenotyping. Comprehensive metabolic,
behavioral, and physiological variables were determined by TSE/PhenoMaster
at the Washington University Diabetes Models Phenotyping Core. Body
composition was analyzed using EchoMRI (Echo Medical Systems) for mea-
suring the percentage body fat and lean mass in awake animals. For meta-
bolic phenotyping, mice were fed a chow diet or high-fat diet for 20 wk.
Animals were acclimated to the core facility for 1 wk prior to experimentation,
then for an additional 24 h in individual metabolic cages prior to data col-
lection. Parameters measured include oxygen (O2) consumption, carbon di-
oxide (CO2) production, energy expenditure, locomotor activity, and food and
water intake. The respiratory exchange ratio (RER) was calculated as the ratio
of CO2 production to O2 consumption: RER = VCO2/VO2. Data were analyzed
by CalR using a general linear model modified from analysis of covariance
(ANCOVA) and ANOVA by accounting for mass effects in calorimetry studies
(73, 74).
Live-Cell Calcium Imaging. Islets were incubated with 4 μM of Fluo4-AM for
45 min at 37 °C, 5% CO2 in KRBH buffer (pH 7.4, 0.1% BSA) containing 2 mM
glucose. Islets were equilibrated for 5 min in a climate-controlled microscope
stage at 37 °C, 5% CO2. All imaging experiments were performed with
glucose concentrations at a steady state. All experiments took place in 2 mL
buffer volume using MatTek glass bottom microwell dishes No. 1.5 (0.16 to
0.19 mm). In select experiments (SI Appendix, Fig. S5), islets were pre-
incubated with 100 nM somatostatin for 1 h prior to Fluo-4 labeling. Results
were representative of five independent experiments; islets from both male
and female mice were examined. Confocal imaging was conducted using a
Zeiss 880 microscope on Fluo4-AM-labeled islets with 488 nm laser excita-
tion, and emission was detected at 500 to 570 nm using a spectral detector.
Images were captured using a Zeiss Plan-Apochromat 63× 1.4 oil immersion
differential interference contrast objective and acquired at a frame size of
512 × 512 (135 × 135 μm2) with a pixel dwell time of 2.06 μs, resulting in a
frame time of 0.633 s. The pinhole size was kept at 206.6 μm to allow for
sufficient signal-to-noise ratio. Baseline time series images at 2 mM glucose
were acquired for 320 s. Glucose concentration was then increased to 8 mM
by manual pipetting. After glucose addition, the islet position and imaging
plane were checked and adjusted if necessary. Islets were allowed to
equilibrate for another 2 min, followed by multiple imaging series of 320-s
cycles. Image series were concatenated, drift was corrected by the Nano
J-Core ImageJ plugin (75), and intensity profiles and kymographs were
generated for quantification.
Transmission Electron Microscopy. Islet ultrastructure was assessed with
electron microscopy. Isolated islets are fixed in Karnovsky’s solution (3%
glutaraldehyde, 1% paraformaldehyde), followed by a secondary fixation in
osmium tetroxide, dehydrated in alcohol, embedded in resin, and poly-
merized at 90 °C for 48 h. Ultrathin sections of 90 nm thickness were cut and
stained with uranyl acetate and examined with a JEOL 1200 EX.
Protein Expression Arrays. The Phospho Explorer Antibody Array (PEX100) and
Signaling Explorer Antibody array (SET100) were manufactured by Full Moon
Biosystems. Two groups of two βCKO and two untreated βCKO-ERT2 (WT)
control male mice aged 8 to 10 wk were used as experimental replicates.
Total protein was extracted from βCKO and control islet lysates, labeled with
biotin, conjugated to preblocked microarray slides, and detected with Cy3-
streptavidin. Slides were returned to Full Moon BioSystems for scanning. Spot
intensities were extracted from the scanned array images using GenePix 5.
Background readings from each array were subtracted for each spot, and
average median signal was used for analysis. The array was normalized against
total average spot intensity on the array.
Bioinformatics. Differential expression between samples was calculated by
dividing the expression ratio of KO by WT. Proteins with expression fold
change of >1.5 or <0.5 between KO and WT were selected and classified for
functionality using the Gene Ontology database. Those with the lowest FDR,
highest FC, and known role in islet or β-cell regulation were curated into
three functional groups. Heat maps of differentially expressed proteins (P <
0.05) from both arrays were generated via the open resource app Heat-
mapper (76), and gene enrichment analysis was done by Enrichr (77).
Statistics. Data are presented as mean ± SEM. Differences between groups
were compared using t test (two groups) or ANOVA (>two groups).
PhenoMaster data were analyzed by CalR using a general linear model
based on ANCOVA. Sample size and number of replicates for each experiment
are indicated in figure legends. Significant differences among groups with
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 are indicated.
Data Availability. Any data and materials that can be shared will be released
via a Materials Transfer Agreement. The phosphoprotein and signaling array
data have been deposited in the Gene Expression Omnibus under accession
numbers GSE138856 and GSE138885.
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